4//SEC Filing
GENOCEA BIOSCIENCES, INC. 4
Accession 0001283841-16-000004
CIK 0001457612operating
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 5:38 PM ET
Size
6.7 KB
Accession
0001283841-16-000004
Insider Transaction Report
Form 4
HETHERINGTON SETH V
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2016-11-09$2.02/sh+5,000$10,100→ 26,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-11-09$2.02/sh−5,000$10,100→ 61,955 totalExercise: $2.02Exp: 2021-02-17→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The option was granted on 2/17/2011 and the vesting schedule was completed in February 2015.
Documents
Issuer
GENOCEA BIOSCIENCES, INC.
CIK 0001457612
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001457612
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 5:38 PM ET
- Size
- 6.7 KB